Clinical Approach to Prostate Disease

  • Danilo Zani
  • Claudio Simeone
  • Sergio Cosciani Cunico


The prostate is the largest gland annexed to the male reproductive system and is made up of a glandular and stromal component. The former, as described by McNeal, can be subdivided into three zones: central, transition and peripheral. The nonglandular part consists of the periprostatic sphincter, the anterior connective tissue and the prostatic capsule.


Chronic Prostatitis Male Reproductive System Prostate Disease Chronic Bacterial Prostatitis Acute Bacterial Prostatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation subcommittee of the International Continence Society. Neurourol Urodyn 21:167–178CrossRefPubMedGoogle Scholar
  2. Nickel JC, Weidner W (2000) Chronic prostatitis: current concepts and antimicrobial therapy. Infect Urol 13:22–28Google Scholar
  3. Pavone Macaluso M, Di Trapani D, Pavone C (1991) Prostatitis, prostatosis and prostalgia. Psychogenic or somatic disease? Scand J Urol Nephrol 138:77–82Google Scholar
  4. Roberts RO, Jacobson DJ, Girman C et al (2002) Prevalence of prostatitis like symptoms in a community based cohort of older men. J Urol 168:2467–2471CrossRefPubMedGoogle Scholar
  5. Roberts RO, Lieber NM, Bostwick DG et al (1997) A review of clinical and pathological prostatitis syndromes. Urology 49:809–821CrossRefPubMedGoogle Scholar
  6. AUA Practice Guidelines Committee (2003) AUA guideline on management of benign prostatic hyperplasia. Chapter 1: Diagnosis and treatment recommendations. J Urol 170:530–547CrossRefGoogle Scholar
  7. Girmar GJ, Jacobsen SJ, Tsukamoto T et al (1998) Health related quality of life associated with lower urinary tract symptom in four countries. Urology 51:428–436CrossRefGoogle Scholar
  8. Jacobsen SJ, Girman CJ, Guess HA et al (1995) New diagnostic and treatment guidelines for benign prostatic hyperplasia. Arch Intern Med 155:477–481CrossRefPubMedGoogle Scholar
  9. Mebust WK, Holtgrewe HL, Cockett ATK (1989) Transurethral prostatectomy: immediate and postoperative complication. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 41:243–247Google Scholar
  10. Walsh PC, Retik AB et al (1998) Campbell’s urology, 7th ed. WB Saunders Co., PhiladelphiaGoogle Scholar
  11. Abbas F, Scardino PT (1997) The natural history of clinical prostate carcinoma. Cancer 80:827–833CrossRefPubMedGoogle Scholar
  12. American Urological Association (AUA) (2000) Prostate specific antigen (PSA) best practice policy. Oncology 14:267–280Google Scholar
  13. Bil Axelson A, Holmberg L, Ruutu M et al (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1977–1984CrossRefGoogle Scholar
  14. Gleason DF (1997) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea & Febiger, Philadelphia, pp 171–198Google Scholar
  15. Mundy GR (1997) Mechanism of bone metastases. Cancer 80:1546–1556CrossRefPubMedGoogle Scholar
  16. Scardino PT (1989) Early detection of prostate cancer. Urol Clin North Am 16:635–655PubMedGoogle Scholar
  17. Sooriakumaran P, Khaksar SJ, Shah J (2006) Management of prostate cancer. Part 2: localized and locally advanced disease. Expert Rev Anticancer Ther 6:595–603CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Danilo Zani
    • 1
  • Claudio Simeone
    • 1
  • Sergio Cosciani Cunico
    • 1
  1. 1.Department of UrologyUniversity of Brescia A. O. Spedali CiviliBresciaItaly

Personalised recommendations